These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30874464)

  • 1. Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations.
    Managuli RS; Wang JT; Faruqu FN; Kushwah V; Raut SY; Shreya AB; Al-Jamal KT; Jain S; Mutalik S
    Nanomedicine (Lond); 2019 Apr; 14(7):889-910. PubMed ID: 30874464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface engineered nanoliposomal platform for selective lymphatic uptake of asenapine maleate: In vitro and in vivo studies.
    Managuli RS; Wang JT; Faruqu FM; Pandey A; Jain S; Al-Jamal KT; Mutalik S
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110620. PubMed ID: 32228915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
    Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
    Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies.
    Patel M; Mundada V; Sawant K
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):144-153. PubMed ID: 30669881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
    Singh A; Neupane YR; Mangla B; Kohli K
    J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
    Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects.
    Dong Z; Iqbal S; Zhao Z
    AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine.
    Chen Y; Yuan L; Zhou L; Zhang ZH; Cao W; Wu Q
    Int J Nanomedicine; 2012; 7():4581-91. PubMed ID: 22942642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Mirabegron-loaded Nanostructured Lipid Carriers for Improved Bioabsorption: Formulation, Statistical Optimization, and In-Vivo Evaluation.
    Shah P; Patel M; Kansara Y; Vyas B; Prajapati P; Pradhan M; Jain S
    AAPS PharmSciTech; 2024 Sep; 25(7):222. PubMed ID: 39322792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.
    Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q
    Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Drug Delivery Approach via Self-Microemulsifying Drug Delivery System for Enhancing Oral Bioavailability of Asenapine Maleate: Optimization, Characterization, Cell Uptake, and In Vivo Pharmacokinetic Studies.
    Patel MH; Mundada VP; Sawant KK
    AAPS PharmSciTech; 2019 Jan; 20(2):44. PubMed ID: 30617712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect.
    Yin J; Hou Y; Yin Y; Song X
    Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption.
    Zhu Y; Liang X; Lu C; Kong Y; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H
    Int J Pharm; 2020 Aug; 586():119569. PubMed ID: 32592899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.